Deal watch: AstraZeneca bets on FibroGen's anaemia drug.Published in:Nature Reviews Drug Discovery, 2013, v. 12, n. 10, p. 730, doi. 10.1038/nrd4135By:Flight, Monica HoyosPublication type:Article
First-in-class anemia drug takes aim at Amgen's dominion.Published in:Nature Biotechnology, 2013, v. 31, n. 11, p. 948, doi. 10.1038/nbt1113-948bBy:Bouchie, AaronPublication type:Article